The experimental coronavirus treatment remdesivir has failed in its first randomized clinical trial, inadvertently released results showed on Thursday, dampening expectations for the closely watched drug.
A draft summary went online briefly on the WHO Web site and was first reported by the Financial Times and health news Web site Stat, which posted a screenshot.
However, Gilead Sciences, the company behind the medicine, disputed how the now-deleted post had characterized the findings, saying that the data showed a “potential benefit.”
Photo: AFP
The Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group, the summary said, adding that remdesivir was stopped early in 18 patients because of side effects.
The authors said that remdesivir was “not associated with a difference in time to clinical improvement” compared with the control.
After a month, 13.9 percent of the patients on remdesivir had died, compared with 12.8 percent of those in the control group. The difference is not statistically significant.
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.
“We believe the post included inappropriate characterizations of the study,” a Gilead spokesman told reporters, adding that it was terminated early due to low enrollment and was therefore not statistically meaningful.
“As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease,” the spokesman said.
The study does not represent the final word on the matter, and there are several large-scale trials in advanced stages that should soon provide a clearer picture.
Remdesivir, which is administered intravenously, was among the first drugs suggested as a treatment for the novel coronavirus and as such has great hopes riding on it.
Last week, Stat reported that it had shown significant efficacy at a Chicago hospital where patients who are part of one of the major trials are being treated.
The US National Institutes of Health also reported it that had proven effective in a small experiment on monkeys.
Remdesivir, which previously failed in trials against Ebola, belongs to a class of drugs that act on the virus directly — as opposed to controlling the abnormal and often lethal autoimmune response it causes. It mimics one of the four building blocks of RNA and DNA, and gets absorbed into the virus’ genome, which in turn stops the pathogen from replicating.
Anti-malarial drugs hydroxychloroquine and chloroquine have also been widely used on COVID-19 on a so-called “compassionate basis” pending results from large trials, with early studies decidedly mixed.
Other therapies that are being studied include collecting antibodies from COVID-19 survivors and injecting them in patients, or harvesting antibodies from genetically engineered mice that were deliberately infected.
Separately in France, new research shows that nicotine could protect people from contracting COVID-19.
The findings came after researchers at a top Paris hospital examined 343 COVID-19 patients, as well as 139 people with the illness who had milder symptoms.
They found that a low number of them smoked, compared with smoking rates of about 35 percent in France’s general population.
“Among these patients, only 5 percent were smokers,” said Zahir Amoura, the study’s coauthor and a professor of internal medicine.
The research echoed similar findings published in the New England Journal of Medicine last month suggesting that 12.6 percent of 1,000 people infected in China were smokers.
That was a much lower figure than the number of regular smokers in China’s general population, about 26 percent, WHO data showed.
The theory is that nicotine could adhere to cell receptors, therefore blocking the novel coronavirus from entering cells and spreading in the body, said neurobiologist Jean-Pierre Changeux from France’s Pasteur Institute, who also coauthored the study.
The researchers are awaiting approval from health authorities to carry out further clinical trials.
The researchers are looking into whether nicotine could help to prevent “cytokine storms,” a rapid overreaction of the immune system that scientists think could play a key role in fatal COVID-19 cases.
However, with further research needed, experts are not encouraging people to pick up smoking or use nicotine patches as a protective measure against the virus.
“We must not forget the harmful effects of nicotine,” French Director-General for Health Jerome Salomon said.
“Those who do not smoke should absolutely not use nicotine substitutes,” which cause side effects and addiction, he said.
Crowds in Bangladesh are flocking to snap photographs with an unlikely social media star — an albino buffalo with flowing blond hair nicknamed “Donald Trump” that is due to be sacrificed within days. Owner Zia Uddin Mridha, 38, said his brother named the 700kg bull over its flowing helmet of hair resembling the signature look of the US president. “My younger brother picked this name because of the buffalo’s extraordinary hair,” he said at his farm in Narayanganj, just outside the capital, Dhaka. Mridha said that a constant stream of curious visitors — social media fans, onlookers and children — have come throughout
The Bolivian government on Friday struck a deal with protesting miners, but was still grappling with blockades and demonstrations by other workers across La Paz. Other groups are still blocking access roads into the city, which is also the seat of the government. Police on Thursday prevented the miners from entering the main square by using tear gas, while the demonstrators hurled stones and explosives with slingshots. Protests against the policies of Bolivian President Rodrigo Paz have convulsed the Andean nation since early this month, and roadblocks were choking routes into La Paz throughout Friday, the national road authority said. Miners demanded that Paz
The Philippines said it has asked the country’s Supreme Court to allow it to arrest former Philippine president Rodrigo Duterte’s chief drug war enforcer to stand trial in an international tribunal. The International Criminal Court (ICC) last week unsealed an arrest warrant against Philippine Senator Ronald dela Rosa, accusing him along with Duterte and other “coperpetrators” of the “crime against humanity of murder.” Dela Rosa briefly sought refuge in the Philippine Senate last week while asking the Philippine Supreme Court to stop an ongoing attempt by government agents to arrest him. “By his own conduct, he has placed himself outside the protection of
The researchers in Ireland looked at their computer screen, marveling at a medieval book tracked down in a Roman library. They flipped through its digitized pages and found their sought-after treasure: the oldest surviving English poem. “We were extremely surprised. We were speechless. We couldn’t believe our eyes when we first saw that,” said Elisabetta Magnanti, a visiting research fellow at Trinity College Dublin’s school of English. The poem was also within the main body of Latin text, she said, calling it “extraordinary.” Composed in Old English by a Northumbrian agricultural worker in the 7th century, Caedmon’s Hymn appears within some copies of
RSS